Showing results (11-20 of 23,903) with videos related to
Sort By:
Pageof 2,391
Biomedicines|August 23, 2020
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical IndicationsYang Liu, Fengchao Lang, Fu-Ju Chou, et al.Molecular Cancer Therapeutics|September 25, 2019
Blockade of Glutathione Metabolism in IDH1-Mutated GliomaXiaoying Tang, Xiao Fu, Yang Liu, et al.Pharmacology & Therapeutics|October 3, 2025
Targeting cell cycle checkpoints for glioma therapyFengchao Lang, Chunzhang YangJournal of the National Cancer Institute|February 14, 2019
Targeting IDH1-Mutated Malignancies with NRF2 BlockadeYang Liu, Yanxin Lu, Orieta Celiku, et al.Cancers|April 1, 2020
mTORC2/Rac1 Pathway Predisposes Cancer Aggressiveness in IDH1-Mutated GliomaYang Liu, Yanxin Lu, Aiguo Li, et al.Proceedings of the National Academy of Sciences of the United States of America|April 22, 2020
Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolismDi Yu, Yang Liu, Yiqiang Zhou, et al.Molecular Therapy. Nucleic Acids|April 27, 2016
Application of Peptide Nucleic Acid-based Assays Toward Detection of Somatic MosaicismChristopher S Hong, Chunzhang Yang, Zhengping ZhuangJournal of Inherited Metabolic Disease|July 21, 2012
An innovative approach to the treatment of Gaucher disease and possibly other metabolic disorders of the brainRoscoe O Brady, Chunzhang Yang, Zhengping ZhuangBritish Journal of Cancer|April 16, 2020
IDH mutation in glioma: molecular mechanisms and potential therapeutic targetsSue Han, Yang Liu, Sabrina J Cai, et al.Journal of the National Cancer Institute|August 14, 2013
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right directionIvana Jochmanová, Chunzhang Yang, Zhengping Zhuang, et al.Pageof 2,391